POINT ROBERTS - November 2, 2011 –Investorideas.com, a leader in sector research for independent investors issues the following commentary for nanotech stocks and drug delivery as part of the ongoing content series “follow the money in Nanotechnology.”
According to Cientifica's recent report, Nanotechnology in Drug Delivery 2011,"
The healthcare market is poised to see some of the earliest benefits of nanotechnology. Over the next decade, it will be one of nanotech's highest growth sectors. Targeted drug delivery therapies for the treatment of cancer is one of the most commonly cited nano-healthcare benefits.
- Published: 01 November 2011
- Written by Investor Ideas